Abstract:Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.

ATM activity contributes to the tumor-suppressing functions of p14 ARF

[Interaction Between ATM and Radiation-Activated Phosphorylation of P53 and P21].

Identification of an Ataxia Telangiectasia-Mutated Protein Mediated Surveillance System to Regulate Bcl-2 Overexpression

ATM and P21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development.

ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress.

Chfr and RNF8 Synergistically Regulate ATM Activation

P14arf Interacts with E2F Factors to Form P14arf–e2f/partner‐dna Complexes Repressing E2F‐dependent Transcription

ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor

ARF Triggers Cell G1 Arrest by a P53 Independent ERK Pathway

Mir-18A Impairs DNA Damage Response Through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase.

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of P53/p21waf1/cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer.

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I

The DNA repair kinase ATM regulates CD13 expression and cell migration

P14ARF: The Absence that Makes the Difference

Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.

P14arf Sensitizes Human Osteosarcoma Cells to Cisplatin-Induced Apoptosis in A P53-Independent Manner

Involvement of P53 and P21 in Cellular Defects and Tumorigenesis in Atm−/− Mice

ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.

RPRM negatively regulates ATM levels involving its phosphorylation mediated by CDK4/CDK6